132 related articles for article (PubMed ID: 12467220)
1. Inhibition of growth of human prostate cancer xenograft by transfection of p53 gene: gene transfer by electroporation.
Mikata K; Uemura H; Ohuchi H; Ohta S; Nagashima Y; Kubota Y
Mol Cancer Ther; 2002 Feb; 1(4):247-52. PubMed ID: 12467220
[TBL] [Abstract][Full Text] [Related]
2. High antitumor activity using intratumoral injection of plasmid DNA with mutant-type p27Kip1 gene following in vivo electroporation.
Harada K; Supriatno ; Kawaguchi S; Onoue T; Kawashima Y; Yoshida H; Sato M
Oncol Rep; 2005 Feb; 13(2):201-6. PubMed ID: 15645112
[TBL] [Abstract][Full Text] [Related]
3. p53 and PTEN/MMAC1/TEP1 gene therapy of human prostate PC-3 carcinoma xenograft, using transferrin-facilitated lipofection gene delivery strategy.
Seki M; Iwakawa J; Cheng H; Cheng PW
Hum Gene Ther; 2002 Apr; 13(6):761-73. PubMed ID: 11936974
[TBL] [Abstract][Full Text] [Related]
4. Suppression of primary tumor growth and the progression to metastasis with p53 adenovirus in human prostate cancer.
Eastham JA; Grafton W; Martin CM; Williams BJ
J Urol; 2000 Sep; 164(3 Pt 1):814-9. PubMed ID: 10953161
[TBL] [Abstract][Full Text] [Related]
5. Combinatory anti-tumor effects of electroporation-mediated chemotherapy and wild-type p53 gene transfer to human esophageal cancer cells.
Matsubara H; Maeda T; Gunji Y; Koide Y; Asano T; Ochiai T; Sakiyama S; Tagawa M
Int J Oncol; 2001 Apr; 18(4):825-9. PubMed ID: 11251180
[TBL] [Abstract][Full Text] [Related]
6. [In vitro and in vivo inhibitory effect of Ad-ING4 gene on proliferation of human prostate cancer PC-3 cells].
Yang HC; Sheng WH; Xie YF; Miao JC; Wei WX; Yang JC
Ai Zheng; 2009 Nov; 28(11):1149-57. PubMed ID: 19895734
[TBL] [Abstract][Full Text] [Related]
7. Molecular therapy with recombinant p53 adenovirus in an androgen-independent, metastatic human prostate cancer model.
Ko SC; Gotoh A; Thalmann GN; Zhau HE; Johnston DA; Zhang WW; Kao C; Chung LW
Hum Gene Ther; 1996 Sep; 7(14):1683-91. PubMed ID: 8886839
[TBL] [Abstract][Full Text] [Related]
8. A preclinical model of minimal residual cancer in the muscle highlights challenges associated with adenovirus-mediated p53 gene transfer.
Oakley R; Phillips E; Hooper R; Wilson D; Partridge M
Clin Cancer Res; 2002 Jun; 8(6):1984-94. PubMed ID: 12060644
[TBL] [Abstract][Full Text] [Related]
9. Enhanced p53 gene transfer to human ovarian cancer cells using the cationic nonviral vector, DDC.
Kim CK; Choi EJ; Choi SH; Park JS; Haider KH; Ahn WS
Gynecol Oncol; 2003 Aug; 90(2):265-72. PubMed ID: 12893186
[TBL] [Abstract][Full Text] [Related]
10. Effects of electrogenetherapy with p53wt combined with cisplatin on curvival of human tumor cell lines with different p53 status.
Cemazar M; Grosel A; Glavac D; Kotnik V; Skobrne M; Kranjc S; Mir LM; Andre F; Opolon P; Sersa G
DNA Cell Biol; 2003 Dec; 22(12):765-75. PubMed ID: 14683587
[TBL] [Abstract][Full Text] [Related]
11. Effect of intratumoral injection of mutant type p27Kip1 followed by in vivo electroporation on radiotherapy-resistant human oral tongue cancer xenografts.
Supriatno ; Yuletnawati SE; Widiasto A
Mol Med Rep; 2011; 4(1):41-6. PubMed ID: 21461561
[TBL] [Abstract][Full Text] [Related]
12. Synergistic antitumor effect of combined use of adenoviral-mediated p53 gene transfer and antisense oligodeoxynucleotide targeting clusterin gene in an androgen-independent human prostate cancer model.
Yamanaka K; Gleave ME; Hara I; Muramaki M; Miyake H
Mol Cancer Ther; 2005 Feb; 4(2):187-95. PubMed ID: 15713890
[TBL] [Abstract][Full Text] [Related]
13. Gene transfer of interleukin 13 receptor alpha2 chain dramatically enhances the antitumor effect of IL-13 receptor-targeted cytotoxin in human prostate cancer xenografts.
Kawakami K; Husain SR; Bright RK; Puri RK
Cancer Gene Ther; 2001 Nov; 8(11):861-8. PubMed ID: 11773976
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumor effect of adenoviral vector-mediated p53 gene transfer on the growth of canine osteosarcoma xenografts in nude mice.
Kanaya N; Yazawa M; Goto-Koshino Y; Mochizuki M; Nishimura R; Ohno K; Sasaki N; Tsujimoto H
J Vet Med Sci; 2011 Jul; 73(7):877-83. PubMed ID: 21350316
[TBL] [Abstract][Full Text] [Related]
15. Reduction of wild type p53 function confers a hormone resistant phenotype on LNCaP prostate cancer cells.
Burchardt M; Burchardt T; Shabsigh A; Ghafar M; Chen MW; Anastasiadis A; de la Taille A; Kiss A; Buttyan R
Prostate; 2001 Sep; 48(4):225-30. PubMed ID: 11536301
[TBL] [Abstract][Full Text] [Related]
16. Synergistic suppression of prostatic cancer cells by coexpression of both murine double minute 2 small interfering RNA and wild-type p53 gene in vitro and in vivo.
Ji K; Wang B; Shao YT; Zhang L; Liu YN; Shao C; Li XJ; Li X; Hu JD; Zhao XJ; Xu DQ; Li Y; Cai L
J Pharmacol Exp Ther; 2011 Jul; 338(1):173-83. PubMed ID: 21444629
[TBL] [Abstract][Full Text] [Related]
17. [Effects of exogenous wild type p53 on malignant growth of human lung cancer cell line].
Wang H; Lai B; Li J
Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):268-72. PubMed ID: 11326947
[TBL] [Abstract][Full Text] [Related]
18. Dominant-negative p53 mutations in rheumatoid arthritis.
Han Z; Boyle DL; Shi Y; Green DR; Firestein GS
Arthritis Rheum; 1999 Jun; 42(6):1088-92. PubMed ID: 10366100
[TBL] [Abstract][Full Text] [Related]
19. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
Zhang F; Lee J; Lu S; Pettaway CA; Dong Z
Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637
[TBL] [Abstract][Full Text] [Related]
20. Transfected neu oncogene induces human prostate cancer metastasis.
Zhau HY; Zhou J; Symmans WF; Chen BQ; Chang SM; Sikes RA; Chung LW
Prostate; 1996 Feb; 28(2):73-83. PubMed ID: 8604395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]